Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Junya Kanda

Showing results (81-90 of 422) with videos related to

Pageof 43
Sort By:
Transfusion|January 28, 2009
Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studiesJunya Kanda, Tatsuo Ichinohe, Keitaro Matsuo, et al.
Cytotherapy|October 16, 2021
Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor eraAkira Ishii, Tomoyasu Jo, Yasuyuki Arai, et al.
British Journal of Haematology|July 9, 2025
Consistent ex vivo cell proliferation during manufacturing predicts favourable outcomes post-CAR-T-cell therapyTomoyasu Jo, Yasuyuki Arai, Tomoshige Shimizu, et al.
International Journal of Hematology|December 11, 2012
Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantationSoichiro Sakamoto, Hiroshi Kawabata, Junya Kanda, et al.
Blood Advances|October 10, 2025
Survival in adults with high-risk TA-TMA: a comparative analysis of narsoplimab vs supportive careHiroyuki Matsui, Yasuyuki Arai, Junya Kanda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 21, 2025
Factors affecting the condition and prognosis of patients with late-onset noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation: a propensity score-matched studyRyota Hamada, Yohei Oshima, Susumu Sato, et al.
Scientific Reports|April 5, 2026
Retrospective analysis of clinical outcomes and risk factors in hematopoietic cell transplantation for relapsed or refractory mantle cell lymphoma in the post-ibrutinib eraSatoshi Yamasaki, Yutaka Shimazu, Yukiko Misaki, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 13, 2021
Analysis of factors associated with patient-reported physical functioning scores at discharge of allogeneic hematopoietic stem cell transplantation patients: a cross-sectional studyMasanobu Murao, Ryota Hamada, Tadakazu Kondo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 19, 2020
Detection of adenovirus hepatitis and acute liver failure in allogeneic hematopoietic stem cell transplant patientsYoshiyuki Onda, Junya Kanda, Soichiro Sakamoto, et al.
International Journal of Hematology|November 17, 2025
Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapyYusuke Tashiro, Tomoyasu Jo, Toshio Kitawaki, et al.
Pageof 43

Showing results (81-90 of 422) with videos related to

Sort By:
Pageof 43
Transfusion|January 28, 2009
Impact of ABO mismatching on the outcomes of allogeneic related and unrelated blood and marrow stem cell transplantations for hematologic malignancies: IPD-based meta-analysis of cohort studiesJunya Kanda, Tatsuo Ichinohe, Keitaro Matsuo, et al.
Cytotherapy|October 16, 2021
Development of a quantitative prediction model for peripheral blood stem cell collection yield in the plerixafor eraAkira Ishii, Tomoyasu Jo, Yasuyuki Arai, et al.
British Journal of Haematology|July 9, 2025
Consistent ex vivo cell proliferation during manufacturing predicts favourable outcomes post-CAR-T-cell therapyTomoyasu Jo, Yasuyuki Arai, Tomoshige Shimizu, et al.
International Journal of Hematology|December 11, 2012
Differing impacts of pretransplant serum ferritin and C-reactive protein levels on the incidence of chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantationSoichiro Sakamoto, Hiroshi Kawabata, Junya Kanda, et al.
Blood Advances|October 10, 2025
Survival in adults with high-risk TA-TMA: a comparative analysis of narsoplimab vs supportive careHiroyuki Matsui, Yasuyuki Arai, Junya Kanda, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|November 21, 2025
Factors affecting the condition and prognosis of patients with late-onset noninfectious pulmonary complications after allogeneic hematopoietic stem cell transplantation: a propensity score-matched studyRyota Hamada, Yohei Oshima, Susumu Sato, et al.
Scientific Reports|April 5, 2026
Retrospective analysis of clinical outcomes and risk factors in hematopoietic cell transplantation for relapsed or refractory mantle cell lymphoma in the post-ibrutinib eraSatoshi Yamasaki, Yutaka Shimazu, Yukiko Misaki, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 13, 2021
Analysis of factors associated with patient-reported physical functioning scores at discharge of allogeneic hematopoietic stem cell transplantation patients: a cross-sectional studyMasanobu Murao, Ryota Hamada, Tadakazu Kondo, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|October 19, 2020
Detection of adenovirus hepatitis and acute liver failure in allogeneic hematopoietic stem cell transplant patientsYoshiyuki Onda, Junya Kanda, Soichiro Sakamoto, et al.
International Journal of Hematology|November 17, 2025
Low reticulocyte count at infusion is a risk factor for high-grade cytokine release syndrome in chimeric antigen receptor T cell therapyYusuke Tashiro, Tomoyasu Jo, Toshio Kitawaki, et al.
Pageof 43